MEMOTEXT is a privately held corporation located in Toronto, Ontario, Canada and Bethesda, MD, USA. MEMOTEXT has developed and validated a condition-specific behavior assessment methodology, algorithm and multimedia messaging platform to create significant improvements in patient compliance to medication regimens.
MEMOTEXT is focused on providing healthcare stakeholders with significant increases in medication compliance and patient adherence to therapy. These increases typically provide benefits to patients and the healthcare organizations MEMOTEXT works with.
MEMOTEXT has validated its model with clients including randomized control trials with the Wilmer Eye Clinic at Johns Hopkins University, Green Shield Canada, Boots Pharmacy/Alliance Boots, Biogen Idec Canada, Smith & Nephew/Bioventus, Schering Plough Canada, and other clients under which MEMOTEXT is bound by confidentiality.